GGrantIndex
← Search

A NOVEL TARGETED THERAPY FOR TREATMENT-EMERGENT ANAPLASTIC FORMS OF CASTRATION-RESISTANT PROSTATE CANCER

$824,927FY2022Defense Health AgencyDOD

Queensland University Of Technology, Brisbane

Investigators

View source on USAspending →
A NOVEL TARGETED THERAPY FOR TREATMENT-EMERGENT ANAPLASTIC FORMS OF CASTRATION-RESISTANT PROSTATE CANCER · GrantIndex